Factors Associated With Unplanned Return to Theater in Reconstructive Head and Neck Cancer Patients: A Retrospective Risk Factor Analysis
Microsurgery · 2026
DOI: 10.1002/micr.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microsurgery, 2026. Verfasst von Jevan Cevik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Plastic and Reconstructive Surgery Unit, the Royal Melbourne Hospital, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Plastic Surgery Procedures, Free Tissue Flaps, Postoperative Complications. Die Arbeit nennt 39 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Unplanned return to theater (URTT) following head and neck cancer reconstruction presents significant clinical and economic challenges. Identifying risk factors for URTT can aid in surgical planning and patient risk stratification. This study evaluates preoperative and intraoperative factors associated with URTT in patients undergoing free flap reconstruction after head and neck tumor resection.
Methods
A retrospective cohort study was conducted on patients undergoing head and neck tumor resection with free flap reconstruction between July 2015 and January 2024. Demographic, clinical, and operative data were analyzed using univariable and multivariable logistic regression.
Results
Of 609 patients included, 199 (32.7%) experienced URTT within 90 days postoperatively. Common indications for URTT included infected collections (33.7%), hematoma (24.6%), and flap dehiscence (16.1%). On univariable analysis, preoperative PEG tube use (unadjusted odds ratio (OR) 1.78 [95% confidence interval (CI) 1.03–3.07], p = 0.04), higher frailty index scores (1.27 [1.03–1.58], p = 0.03), longer operative duration (1.15 [1.06–1.24], p < 0.001), use of bony free flaps (2.08 [1.44–3.01], p < 0.001), and tracheostomy (2.09 [1.22–3.56], p = 0.01) were associated with URTT. Yet, on multivariable analysis, only higher frailty index score (adjusted OR 1.32, 95% CI 1.03–1.70, p = 0.03) and use of bony free flaps (adjusted OR 1.92, 95% CI 1.19–3.11, p < 0.01) retained statistical significance.
Conclusions
The findings of this study suggest that frailty and the use of bony free flaps are key risk factors for URTT among reconstructive head and neck cancer patients. These findings support patient risk stratification preoperatively and targeted interventions to reduce the risk of URTT and improve resource utilization in head and neck cancer surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Plastic and Reconstructive Surgery Unit, the Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Parkville, Victoria, Australia.
- Department of Surgery, The Royal Melbourne Hospital, the University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Jevan Cevik, Anand Ramakrishnan
Zitieren
APA
Cevik, J., Zhang, H., Ichikawa, Y., Cheong, E., Li, P., Varma, A., & Ramakrishnan, A. (2026). Factors Associated With Unplanned Return to Theater in Reconstructive Head and Neck Cancer Patients: A Retrospective Risk Factor Analysis. Microsurgery. https://doi.org/10.1002/micr.70167
Vancouver
Cevik J, Zhang H, Ichikawa Y, Cheong E, Li P, Varma A, et al. Factors Associated With Unplanned Return to Theater in Reconstructive Head and Neck Cancer Patients: A Retrospective Risk Factor Analysis. Microsurgery. 2026. doi:10.1002/micr.70167
BibTeX
@article{Cevik2026,
author = {Cevik, Jevan and Zhang, Hao and Ichikawa, Yuichi and Cheong, Edward and Li, Peixuan and Varma, Amrita and Ramakrishnan, Anand},
title = {Factors Associated With Unplanned Return to Theater in Reconstructive Head and Neck Cancer Patients: A Retrospective Risk Factor Analysis},
journal = {Microsurgery},
year = {2026},
doi = {10.1002/micr.70167}
}
EUVIMED